Endo Pharmaceuticals

Endo Pharmaceuticals is an American based top pharmaceutical company based in Chadds Ford, Pennsylvania

Endo Pharmaceuticals is an American based top pharmaceutical company based in Chadds Ford, Pennsylvania.The company was created as a management buyout from DuPont Merck in 1997.

On 23rd May 2012, Endo's shareholders approved a resolution to change the company's name to Endo Health Solutions Inc.

Endo is focused on creating high-value branded products that meet the needs of patients along care pathways for pain management, urology, oncology and endocrinology.

Report: Partnering Deals and Alliances with Endo Pharmaceuticals

Endo Pharmaceuticals is an American based top pharmaceutical company based in Chadds Ford, Pennsylvania.

The company was created as a management buyout from DuPont Merck in 1997.

On 23rd May 2012, Endo's shareholders approved a resolution to change the company's name to Endo Health Solutions Inc.

Endo is focused on creating high-value branded products that meet the needs of patients along care pathways for pain management, urology, oncology and endocrinology.

The company has three core businesses; all focused on advancing innovations that provide better options and outcomes, enabling healthier lives.

Pharmaceuticals – the company offers high-value branded pharmaceuticals and drug deliveries that create innovative new medicines.

Generics– the company manufactures and distributes generic drugs and over-the-counter products (tablets, capsules, liquids, suspensions, creams and ointments).

Devices – provider of healthcare services and manufacturer of medical devices primarily for the urology community.

Health Services– Leading provider of services, devices and procedures for pelvic health.

Endo Pharmaceuticals has an active licensing venture investment and acquisition group charged with analysing and managing all incoming opportunities. Endo has a long history of partnering, building numerous collaborative partnerships

Endo Pharmaceuticals announced over 54 partnering / licensing deals since 2005, with over 16 deals in 2010 alone. Analysis of the partnering deals shows a strong emphasis on partnerships in central nervous system, cancer, musculoskeletal disorders and anaesthetics

Endo Pharmaceuticals has also announced over 10 M&A deals since 2005, with the lead deals being the acquisition of Qualitest Pharmaceuticals and American Medical Systems

Report: Partnering Deals and Alliances with Endo Pharmaceuticals

Examples of recent partnering and licensing deals announced by Endo Pharmaceuticals can be viewed in Current Partnering's Partnering Agreements with Endo 2005-2013 partnering activity review article.

Examples of recent M&A deals announced by Endo Pharmaceuticals can be viewed in Current Partnering's Partnering Agreements with Endo 2005-2013  M&A activity review article.

Our report provides more detailed insight into the details of each deal. See: Partnering Deals and Alliances with Endo Pharmaceuticals

Available reports from Current Partnering

Report: Partnering Deals and Alliances with Endo Pharmaceuticals

Report: Partnering Deals and Alliances with Big Pharma

Available resources for deal coverage for Endo Pharmaceuticals

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Endo company profile, recent partnering, M&A and financing news and articles

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Print Friendly, PDF & Email